- Latest news▼
-
19:32, May 9 Media: Congo-Crimean haemorrhagic fever detected in Spain: one in four out of 10 patients dies
-
15:26, May 9 UK child's hearing is restored using gene therapy for first time
-
13:37, May 9 Science: folic acid protects against spinal splitting at high risk
-
11:25, May 9 Gastric Cancer: salt overuse increases the risk of developing gastric cancer by 39%
-
08:38, May 9 Deadly spider venom saves cells from damage during stroke, heart attack
-
13:11, May 8 Nature Medicine: Alzheimer's risk reaches 95% in elderly with 2 copies of APOE4 gene, study finds
-
10:39, May 8 The Telegraph: AstraZeneca withdrawing Covid vaccine amid lawsuit
-
22:36, May 7 Woman left in 17-day coma ‘burning from the inside out’ after taking ibuprofen for period pain
-
18:44, May 7 Car interior materials emit harmful substances suspected to cause cancer - study
-
16:47, May 7 Daily Mail: eating nuts and seeds can reduce risk of cancer and heart disease
-
14:52, May 7 Red, highly processed meat increases risk of cancer, experts say
-
08:38, May 7 Human brain is getting bigger, scientists believe this could help reduce risk of dementia
-
16:38, May 6 Daily Mail: decaf coffee is high in fibre
-
15:26, May 6 Ministry of Health of Armenia: Laboratory-confirmed measles cases increased by 27 compared to the previous week
-
14:41, May 6 MedicalXpress: Diabetes drug lowers COVID-19 viral load 4-fold, study finds
All materials
Vaccine against Omicron variant expected to be available in March 2022
December 9, 2021 09:47
BioNTech SE and Pfizer Inc. are working together on an effective vaccine against the Omicron variant of the coronavirus. These companies promise to present the finished product by March next year.
According to a press release on the website of the American pharmaceutical company, the serum antibodies produced by the Pfizer-BioNTech vaccine will neutralize this new variant of COVID-19 after three doses. And in the case of two doses, the neutralizing antibodies’ activeness against Omicron is 25 times lower.
Additional research by these companies shows that the current booster shots of Pfizer and BioNTech increase antibody titers by 25 times.
Follow NEWS.am Medicine on Facebook and Twitter
- Video
- Event calendar
- Archive
- Most read
month
week
day
- Scientists identified dangerous health effects for families with gas cookers in their homes 1392
- Scientists discover cell responsible for repairing damaged liver tissue 1348
- Smoking during pregnancy may lead to obese children, study finds 1323
- What role does diet plays in the treatment of bipolar disorder? 1230
- MedicalXpress: Diabetes drug lowers COVID-19 viral load 4-fold, study finds 1054
- Daily Mail: decaf coffee is high in fibre 906
- Red, highly processed meat increases risk of cancer, experts say 841
- Researchers determine how physical activity affects women's health in middle age 818
- Ministry of Health of Armenia: Laboratory-confirmed measles cases increased by 27 compared to the previous week 802
- The Telegraph: AstraZeneca withdrawing Covid vaccine amid lawsuit 723
- Human brain is getting bigger, scientists believe this could help reduce risk of dementia 723
- Daily Mail: eating nuts and seeds can reduce risk of cancer and heart disease 722
- Car interior materials emit harmful substances suspected to cause cancer - study 711
- Woman left in 17-day coma ‘burning from the inside out’ after taking ibuprofen for period pain 531
- Nature Medicine: Alzheimer's risk reaches 95% in elderly with 2 copies of APOE4 gene, study finds 521
- Find us on Facebook
- Poll
How much money from your income are you willing to allocate monthly on health insurance?